House Committee Hears Criticisms of FDA Devices Review Process | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The House of Representatives committee that serves as a government watchdog held a hearing yesterday focused on whether an overstretched Food and Drug Administration is slowing down the advance of new medical devices, hurting the growth of industry, and making venture investors skittish about backing medical device start-ups.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.